List of Figures
Figure 1: Opioids Market, Drivers and Barriers, 2012
Figure 2: Opioids Market, Global, R&D Pipeline by Phase (%), 2012
Figure 3: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase III
Figure 4: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase II
Figure 5: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase I
Figure 6: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase III
Figure 7: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase II
Figure 8: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase I
Figure 9: Opioids Market, M&As by Year, 2005–2012
Figure 10: Opioids Market, M&As by Value ($m), 2005–2012
Figure 11: Opioids Market, Licensing Agreements by Year, 2005–2012
Figure 12: Opioids Market, Licensing Agreements by Value ($m), 2005–2012
Figure 13: Opioids Market, Co-Development Agreements by Year, 2005–2012